A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)
Clinical trial NCT03198949 · COMPLETED
Trial details
- NCT number
- NCT03198949
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2020-09-11
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.